Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.49 |
| ▸ | GBA1 | P04062 | 5/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.42 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.42 |
| ▸ | GJB2 | P29033 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3501420 | 1.00 | SLC2A1 (0.49) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL6950601 | 1.00 | SLC2A1 (0.49) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL9652492 | 1.00 | SLC2A1 (0.49) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL21518296 | 1.00 | SLC2A1 (0.49) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL16395631 | 0.95 | GBA1 (0.56) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL3502893 | 0.95 | GBA1 (0.56) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL7696481 | 0.95 | GBA1 (0.56) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL10388278 | 0.95 | SLC2A1 (0.54) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL11222662 | 0.95 | SLC2A1 (0.54) | SLC2A1GBA1MAPK1LGALS8LGALS3 | |
| SCHEMBL16678877 | 0.95 | SLC2A1 (0.54) | SLC2A1GBA1MAPK1LGALS8LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5981743-A | Cyclic ester ring-opened oligomers and methods of preparation | UNIVERSITY OF MASSACHUSETTS (US) | 1999-11-09 | — | — | US | disclosed |
| EP-0782847-B1 | Aqueous composition containing lipide nonionic vesicles and at least a non coated pigment dispersed in the aqueous phase, process for this preparation, uses | OREAL (FR) | 1998-08-26 | — | — | EP | disclosed |
| WO-1995014705-A1 | USE OF α-D-ALKYLGLUCOPYRANOSIDES AND ESTERS THEREOF IN THE PREPARATION OF PRODRUGS CAPABLE OF CROSSING THE BLOOD-BRAIN BARRIER, PRODRUGS AND THEIR PRECURSORS | BIOEUROPE (FR) | 1995-06-01 | — | — | WO | disclosed |